Not registered yet?
Benefit from an exclusive 10% discount on the regular full pass before August 31st by using the following code:
BioFIT19_Summer_Offer
Missed the Early Bird offer? Do not miss the Summer offer! Read More »
BioFIT 2019 programme is now available
In this brochure, you will find all the information you need about the 8th edition of the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences.
BioFIT 2019 programme is available! Read More »
December 5th 2018 
10.30 am – 12.30 pm
Lille, France
EDCA invites you to a round table during BioFIT to exchange on the hot topic of the new European In Vitro Diagnostic Regulation.
About EDCA:
European Diagnostic Clusters Alliance – EDCA is the first European network serving the competitiveness of the medical diagnostic industry. It federates 8 European clusters and counts 350 companies.
The purpose of EDCA is:
EDCA members:
[Hosted Events] European Diagnostic Clusters Alliance – EDCA Read More »
Many thanks to Ferring for joining BioFIT 2018 as a Silver Sponsor
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and women’s health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years. Today, over one third of the company’s research and development investment goes towards finding innovative and personalised healthcare solutions to help mothers and babies, from conception to birth.
Join key BioFIT 2018 sponsors such as Pfizer, Bayer, Roche, MSD, Boehringer Ingelheim, LFB, GENFIT, VIB, Ferring Pharmaceuticals and Sanofi to have the opportunity to:
For more information about the sponsorship opportunities, visit the dedicated site page.
We are very honoured to count Ferring among the Sponsors of BioFIT 2018 Read More »
Discover who will be attending:
ALMIRALL S.A.
BAYER HEALTHCARE
BOEHRINGER INGELHEIM
EA PHARMA CO., LTD.
ELANCO
FERRING PHARMACEUTICALS
GSK – GLAXOSMITHKLINE
IPSEN INNOVATION
JOHNSON & JOHNSON
JT PHARMA
LEO PHARMA A/S
LFB
LILLY
MARUHO CO.
MERCK
MOCHIDA PHARMACEUTICAL CO., LTD.
MSD
NOVO NORDISK
PFIZER
ROCHE
SANOFI
SERVIER
SUMITOMO DAINIPPON PHARMA
VIRBAC
ZOETIS
|
Meet the Pharma at BioFIT 2018! Read More »
Many thanks to Sanofi for joining BioFIT 2018 as a Gold Sponsor!
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people they serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare.
Join key BioFIT 2018 sponsors such as Pfizer, Bayer, Roche, MSD, Boehringer Ingelheim, LFB, GENFIT, VIB and Sanofi to have the opportunity to:
For more information about the sponsorship opportunities, visit the dedicated site page.
We are very honoured to count Sanofi among the Sponsors of BioFIT 2018 Read More »
PARTNERING DAY
December 3rd, 2018
Fostering Innovation
Boehringer Ingelheim knows what it takes to be innovative and entrepreneurial. From the small factory in 1885 to today’s global pharmaceutical organisation, we know how important it is to nurture and develop emerging science and technology.
Our track record of bringing breakthrough medicines to patients starts with new ideas and new science, and collaborations with external partners play a key role in helping us deliver an innovation-led portfolio. Join us at our partnering day to explore how we can develop the next generation of medicines together.
For more information on our partnering interests please visit: www.boehringer-ingelheim.com/partnering/interests.
Meet our research and partnering team
Research and partnering teams will be available throughtout the day for networking.
|
Register to attend and apply for a one-to-one meeting
Register to attend the event and, if interested, apply for a one-to-one meeting to discuss potential opportunities for partnering with our team.
Deadline: 1st November
|
[Hosted events] Innovation @ Boehringer Ingelheim – PARTNERING DAY Read More »
Many thanks to GENFIT for joining BioFIT 2018 as a Bronze Sponsor!
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diangostics solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology.
Join key BioFIT 2018 sponsors such as Pfizer, Bayer, Roche, MSD, Boehringer Ingelheim, LFB, GENFIT and VIB to have the opportunity to:
They were the BioFIT 2017 sponsors: Sanofi, Pfizer, Bayer, Genfit, Lilly, MSD, Merck, Boehringer Ingelheim, Johnson & Johnson Innovation, Novo Nordisk, LFB, PPRS and Trianni.
For more information about the sponsorship opportunities, visit the dedicated site page.
We are very honoured to count GENFIT among the Sponsors of BioFIT Read More »
The European Genomic Institute for Diabetes (EGID) will host its 5th international symposium: the gut, incretins and diabetes, from December 4th, 2018, Lille.
This biennial event brings an international focus to our work by the joining of the IDEA Summit and the EGID symposium.
The committee and speakers are world leaders in their fields and will present the latest scientific advances in diabetes and related disorders.
This symposium provides an opportunity for young researchers to present their work via poster presentation and to win the “Best Poster Award” of up to 1000 euros.
8.30 – 9.15 AM
WELCOME COFFEE & SYMPOSIUM MATERIAL DISTRIBUTION
9.15 – 9.30 AM
INTRODUCTION AND WELCOMING
9.30 – 10.15 AM
INSIGHTS FROM BARIATRIC SURGERY
RACHEL BATTERHAM
Professor of Obesity, Diabetes and Endocrinology – NIHR Research Professor, Head of UCLH Obesity & Bariatric Services, Head of Center for Obesity Research, Department of Medicine, Rayne Building, University College London
10.15 – 11.00 AM
FOOD AND TYPE 2 DIABETES: RESTORING THE INSIDE OF THE SYSTEM
ROY TAYLOR
Professor of Medicine and Metabolism, Magnetic Resonance Centre, Campus for Ageing and Vitality, Newcastle upon Tyne
11.00 – 11.30 AM
EGID POSTER SESSION
11.30 AM – 1.00 PM
BIOFIT PLENARY SESSION: Seed funds crossing borders: How far and how fast is the early-stage investment market in Biotech globalising?
1:00 PM – 2.30 PM
LUNCH
2.30 – 3.15 PM
INCRETINS, DIABETES AND CV DISEASE
NIKOLAUS MARX
Director of the Medical Cardiology Clinic – Cardiology, pneumonology, angiology, internal intensive care Aachen University Hospital
3.15 – 4.00 PM
GUT-BRAIN GLUCOSE SIGNALING IN THE CONTROL OF ENERGY HOMEOSTASIS
GILLES MITHIEUX
Research Director – CNRS Director of U1213, Nutrition, Diabetes and the Brain
4.00 – 4.30 PM
NETWORKING BREAK
4.30 – 5.15 PM
THERAPEUTIC POTENTIAL OF MULTI-INCRETIN THERAPY – FROM MICE TO MEN
AIMO KANNT
Head of Department, General Metabolism & Obesity, Sanofi
5.15 – 5.30 PM
BEST PAPER AWARD
5.30 – 6.00 PM
CONCLUSION & INVITATION TO THE CHEESE AND WINE COCKTAIL
|
[Hosted events] EGID Symposium Read More »
BioFIT and the WBC Incubator are pleased to announce that they will be putting together a special edition of WBC Club during BioFIT 2018 in Lille. This session, called «Would-be CEO Networking Lunch», will be held on the second day of BioFIT (5th December).
As talented CEOs are so much sought-after by so many stakeholders of the biotech industry, to both launch and drive new companies to success, this special WBC Club session will bring together representatives of emerging start-ups, technology transfer offices, incubators and investing networks as well as CEOs and would-be CEOs to address this crucial issue.
Since 2010, WBC Incubator has validated close to 100 biotech professionals in Belgium for their ability to match and work with scientific founders and entrepreneurs with the collective aim to build together more exciting business plans, stronger investment propositions and faster business development programmes. In Belgium, biotech CEOs and Would-be CEOs meet regularly to discuss business opportunities during so-called WBC Club events.
The «Would-be CEO Networking Lunch» is organised to present the WBC incubation model to BioFIT participants. Please also note that Would-be CEOs will be identified using the BioFIT partnering platform.
Any bioentrepreneur looking for a project to get involved in is welcome to join BioFIT and particularly this would-be CEOs networking lunch. Any incubator or tech transfer entity looking for an entrepreneur to lead their start-up launch projects is also welcome to join.
[Hosted events] WBC Club: Would-be CEO networking lunch Read More »
With more than 1,000 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences.
Learn more
Organised by:
WITH THE SUPPORT OF:
INSTITUTIONAL PARTNERS:
"*" indicates required fields
Palais de la Musique et des Congrès
Place de Bordeaux
67000, Strasbourg, FRANCE
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of BioFIT. And some are passing themselves off as being BioFIT organisation members and asking you to pay. Please note that the BioFIT team will never sell you the BioFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.
